Stocks
REGENXBIO (RGNX) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 618.9% | 215.5% | 789.1% | 2 158% | 3 862% | ||||
| Changes by years, y/y, % | -441pp | -403pp | -216pp | +1 369pp | +27.9% | ||||
REGENXBIO. R&D/CAPEX, %
REGENXBIO. R&D/CAPEX, changes, pp
REGENXBIO (RGNX) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 1 215% | 2 324% | 4 043% | 4 560% | 9 096% | 3 862% | ||
| Changes by years, y/y, % | +707pp | +1 663pp | +2 790pp | +3 417pp | +7 881pp | |||
| Changes by quarters, q/q, % | +72pp | +1 109pp | +1 719pp | +517pp | +4 536pp | |||
